AGP Executive Report

Medical Access: Illinois added sickle cell disease and polyendocrine metabolic ovarian syndrome with chronic pain to its medical cannabis eligibility list, bringing the state’s total to 58 qualifying conditions. Research: A cerebral palsy treatment roundup highlights NTI164, a low-THC cannabinoid formulation being studied for spasticity; researchers say more controlled studies are needed to establish its benefits. Sleep and Anxiety: Recent reports warn that long-term cannabis use may affect sleep quality without obvious symptoms, while too much cannabis may trigger anxiety. Hemp Policy: A reform group urged Congress to keep hemp-derived THC products legal, as debate over restrictions continues.

Sleep Research: A Northwestern study tracking participants over nearly 35 years found cannabis use was linked to poorer objectively measured sleep, even though users did not report sleeping worse. Published in JAMA Network Open, the findings challenge the belief that cannabis reliably improves sleep. Anxiety Research: In mice, a synthetic cannabinoid intensified fear responses to a predator-like scent. Northwestern researchers linked the effect to somatostatin neurons in the brain’s central amygdala, offering clues to why cannabinoids may heighten anxiety in stressful settings. Federal Legal Risks: A Michigan cannabis farm is asking the Sixth Circuit to review a ruling that contracts in the federally illegal industry cannot be enforced, warning it could unsettle legal markets. Hemp Regulation: A reform group is urging Congress to keep hemp-derived THC products legal as Texas restrictions have sharply narrowed what shops can sell. Ballot Stakes: Massachusetts voters will decide in November whether to repeal recreational cannabis sales, a move that could dismantle a multibillion-dollar industry while leaving medical cannabis rules in place.

European Supply: Cantourage and Canadian partner Green Karat are expanding their medical-cannabis partnership after Green Karat secured EU-GMP certification, a step intended to improve supply and add manufacturing capacity in Europe and the UK. CBD and Clinical Research: University of Regina researchers are studying CBD as a possible concussion treatment, while New York regulators approved a trial of THC oral solution for sciatica-related chronic pain. Patient Access: New Jersey signed reforms to expand access to its medicinal cannabis program; a new Maryland law also limits veterinary-board action against vets who discuss cannabis and CBD. Patient Experience: A survey found 80% of cancer patients reported symptom improvements with cannabis use, while a separate review linked cannabis products with sustained improvements in inflammatory arthritis. Both findings warrant careful interpretation, particularly as patient reports are not proof of treatment effectiveness.

Veterinary CBD: A new Maryland law limits boards’ ability to discipline veterinarians for discussing cannabis and CBD, easing a barrier to conversations with pet owners. Pain Research: New York regulators approved a medical trial of an oral THC solution for sciatica-related chronic pain. Federal Access: Washington officials are working to make it easier for medical cannabis businesses to access benefits tied to federal rescheduling. Patient Reports: A survey found 80% of cancer patients who used cannabis reported symptom improvements. CBD & Concussion: University of Regina researchers are exploring CBD as a potential concussion treatment. Patient Access: New Jersey has signed legislation to reform its medicinal cannabis program and expand access.

Cancer Care: In a survey of patients receiving radiation therapy, 80% of cannabis users reported symptom relief and 89% said it improved their quality of life. Pain Research: New York regulators approved a medical cannabis trial using oral THC to treat sciatica-related chronic pain. Dosing: A review found participants inhaled less cannabis as product strength increased, suggesting consumers adjust their intake to potency. CBD and Concussion: University of Regina researchers are studying CBD as a possible concussion treatment; results have not yet been reported. Autism Research: A study reports medical cannabis may help ease anxiety and depression in autistic patients.

Concussion Research: A University of Regina study is testing whether cannabinoids can safely manage pain linked to post-concussion syndrome, as an alternative to opioids. Researchers say the work aims to build clinical understanding, not assume cannabis is effective. U.S. Regulation: Federal rescheduling is drawing a sharper line between state-licensed medical cannabis and adult-use products, creating new compliance challenges for markets where the two systems share operations. Patient Outcomes: A report links cannabis products with sustained improvements in inflammatory arthritis symptoms, though the headline alone does not establish cause and effect. Hemp Market: North Carolina has delayed restrictions on hemp-derived THC products until Dec. 11 after protests; the rules could force some retailers to remove infused products, but their effect on CBD offerings remains unclear.

UK Prescribing Scrutiny: Private medical-cannabis prescriptions have reportedly reached two million, amid renewed concern after a clinic’s depression treatment was linked to a patient’s suicide. In a separate inquest, a GP questioned a clinic’s decision to approve increasing prescriptions without assessing the patient in person. Access and Regulation: UK patients fear shortages as rules change, while the U.S. DEA has opened a Schedule III registration portal for medical-cannabis businesses. Federal THC restrictions on hemp products, due to take effect in December, are also creating uncertainty for businesses. Research and Safety: Cannabis-based products were associated with sustained improvement in inflammatory arthritis patients, while new coverage examines cannabis-related anxiety and warnings about medical use.

Medical Cannabis Safety: England’s patient safety commissioner warns that nearly 2 million unlicensed medical cannabis items were privately prescribed over the past year, raising concerns about online access and patient risk. Neuroscience & Anxiety: Northwestern researchers pinpoint somatostatin neurons in the central amygdala that may drive cannabinoid-related anxiety, especially under stressful conditions. Pediatric Care: Canada rolls out national guidance for pediatric hospitals to help clinicians screen and respond to youth substance use, including cannabis. Clinical Incident: A Stoughton, Massachusetts student was hospitalized after consuming THC edibles, prompting district-wide family messaging and extra counseling support. Delivery & Access: A Colorado start-up pitches itself as the “DoorDash of cannabis delivery,” aiming to connect licensed dispensaries with licensed transporters to improve compliance and access. Policy & Oversight: Oklahoma lawmakers launch an interim study on abandoned marijuana grow sites and who should pay for cleanup as complaints surge. Legal/Industry: A Georgia Supreme Court ruling revives a hemp grower’s compensation fight after alleged damage from a 2021 drug-suppression air operation. School/Community Impact: Milwaukee Public Schools faces scrutiny after a woman accused of impersonating a substitute teacher and making lewd comments; defense cites a manic episode tied to delayed meds.

Medical Cannabis Access & Supply: The Netherlands’ health ministry won’t renew its contract with licensed grower Bedrocan, raising supply fears for ~7,000 patients as rules to let suppliers sell directly to pharmacies are delayed; the government says it will import, but extra stocks may expire mid-2027. Clinical Outcomes: UK registry data in inflammatory arthritis patients found sustained improvements in pain, sleep, and quality of life with medical cannabis preparations, with mostly mild side effects and fewer than 15% reporting adverse events over 24 months. Policy & Oversight: Tennessee lawmakers held hearings on a limited medical marijuana program, but the state’s top law enforcement (TBI) opposed it as a public-safety and environmental threat. Legal/Regulatory Politics: Idaho voters will decide whether to strip citizen ballot initiatives and give the legislature sole authority over marijuana and other drugs via HJR 4. Public Safety & Enforcement: Coventry police charged a man after discovering a cannabis farm with 100+ plants and electricity abstraction; separate reports also note cannabis-related roadside actions and ongoing drug enforcement. Research & Risk: A large review linked cannabis use with higher odds of committing and experiencing violence, including stronger associations among psychiatric patients.

Legal Pressure on Hemp Access: A coalition asked the D.C. Circuit to revive a CMS hemp program case, arguing patients should keep access to federally legal hemp products. State Cannabis Rules, Worker Safety: Manitoba proposed changes to its cannabis storefront rules, including removing required window coverings and adding authority to set minimum staffing during higher-risk hours. Medical Cannabis in the Spotlight: A new VA records review says cannabis use disorder diagnoses among veterans rose, but the report questions how much is real use versus shifting diagnostic rules. North Carolina Intoxicating Hemp Pushback: HB 328 remains stuck in the House after the Senate approved a conference report that would tighten or remove many intoxicating hemp products from retail. Michigan Consumer Protection: Gov. Whitmer signed bills requiring education on the risks of tobacco and cannabis use for families and schools. Industry/Community Support: Cannatrol partnered with Operation Green Healing as an exclusive nonprofit partner for its veterans-focused limited-edition cannabis curing program. Courtroom Ripples: A Michigan court found a pot cultivator illegally destroyed protected wetlands to build a cannabis farm.

Cannabis Science: Northwestern researchers report a specific set of brain cells in mice (somatostatin neurons in the central amygdala) that appear to drive anxiety-like behavior after cannabinoid exposure, especially under stressful conditions—an angle that could help explain why some cannabis experiences turn bad fast. Medical Cannabis (Veterinary): Endovia and Lupvindol say the FDA has granted CannEpil’s proposed use for canine bone cancer pain “minor use” status under the MUMS program, putting it on track for a conditional approval pathway. Policy & Compliance (U.S. tax): Federal officials say marijuana tax guidance tied to federal rescheduling will be a priority in the 2026–2027 guidance plan, aiming to clarify how 280E applies to cannabis operators. Industry & Deals: Curaleaf increased its offer to acquire Aurora Cannabis, raising cash and share terms as it pushes toward a formal due diligence process. Public Health & Safety: A coalition is urging Canada to ban smoking and vaping in national parks, citing wildfire risk, litter, and youth exposure. Community/Wellness: Cannatrol partnered with Operation Green Healing to support veterans and military families through its Cool Cure limited-edition cannabis curing program.

Medical Access & Marketing Scrutiny: Australia’s online medicinal cannabis prescriber Medicinal Organic Cannabis Australia (MOCA) admitted it wrongly described its products as TGA-approved, despite most medicinal cannabis products not being assessed by the regulator—raising fresh concerns about how clinics and retailers market “approval” language to patients. Workplace Policy: A new report says more employees are testing positive for marijuana at work, even as some employers relax cannabis screening—shifting risk toward workers’ comp and liability and putting more pressure on how employers manage drug-use policies. Veterans Wellness Partnerships: Cannatrol’s Cool Cure Limited Edition program added Operation Green Healing as its exclusive veterans nonprofit partner, with a share of sales funding veterans’ wellness and education programs. Drug Enforcement: Nigeria’s NDLEA reported major port seizures worth over N5bn, including “Thai Loud” cannabis and large codeine-cough syrup consignments, plus cannabis destruction in Osun. Medical Cannabis & Mental Health Claims: A Four Corners investigation highlights alleged aggressive DVA-funded high-THC cannabis prescribing to veterans, with doctors questioning how patients were functioning.

Medical Hemp Legal Watch: Georgia’s Supreme Court revived a hemp grower’s fight after police allegedly destroyed $37,000 of legal hemp during a “drug-suppression” exercise, overturning decades of precedent that had shielded government from compensation claims. Public Policy & Access: North Carolina’s cannabis advisory council is drafting a state public consumption framework ahead of a Dec. 31 deadline, with officials stressing that legal possession doesn’t equal a right to consume in public. Medical Hemp Industry & Wellness: Cannatrol’s Cool Cure Limited Edition program adds Operation Green Healing as its exclusive nonprofit partner for veterans and military families, tying sales to ongoing funding for “alternative wellness” education. Enforcement & Market Pressure: UK police reported cannabis-related stops and seizures during proactive patrols, while separate reports show ongoing international drug interdictions (including a Lagos airport cocaine bust). Research & Treatment Context: A large U.S. study links teen cannabis use to flattened cognitive development, adding to the growing clinical debate around long-term outcomes.

Hemp/CBD Policy Shock: Oregon retailers say a new federal THC rule could force many hemp operators to shut down, with one CBD shop planning to close as pet tinctures and topicals lose access. Youth Cannabis Research: A large U.S. study links teen cannabis use to slower cognitive development, with new findings suggesting adolescents’ mental improvement may lag behind non-users. Cannabis Public Use Rules: North Carolina’s cannabis advisory panel is drafting a public consumption framework ahead of a Dec. 31 deadline, comparing approaches from Virginia, California, and Colorado. Medical Psychedelics Funding: St. Joseph’s Healthcare Hamilton secured $2M for a Centre for Health Innovation and Research in Psychedelics to support Health Canada–endorsed clinical trials for conditions including chronic pain, addiction, and treatment-resistant depression. Addiction Treatment Innovation: A small pilot reports music therapy reduced cravings and changed brain activity patterns in people in alcohol/drug treatment. Legal/Enforcement: A federal judge tossed a drug case after ruling warrantless use of automated license-plate cameras to track travel history violated the Fourth Amendment.

Medical Cannabis & Compliance: Australia’s medicinal cannabis market is tightening fast as regulators focus on prescribing, advertising, and product quality, with Cann Group flagging softer domestic sales and a push toward pharmaceutical-grade exports. Youth Cannabis Risks: A large U.S. study links teen cannabis use to slower cognitive development over adolescence, raising concerns about brain changes during this stage. Cannabis in Criminal Cases: New York prosecutors reopened a Cornell University sexual assault investigation after a civil lawsuit accused seven fraternity members of gang rape involving ketamine, alcohol, and marijuana. Public Health & Drug Supply: A pilot study in Estonia found synthetic opioid cychlorphine detected in many people who inject drugs despite no self-reports, pointing to misidentification and substitution in the drug market. Enforcement & Seizures: Pune Customs seized 1.243 kg of suspected hashish hidden in cosmetic jars at the airport, valued at about ₹1 crore. Industry/Community: Cannatrol partnered with Operation Green Healing to fund veterans’ wellness through its Cool Cure Limited Edition program. Local Impact: Oklahoma officials say they cut marijuana grow sites from 470 to 33, while raising questions about abandoned grows and leftover contamination.

Medical Access Policy (Georgia): Georgia’s Medical Cannabis Commission has approved new rules for medical cannabis delivery, with the plan headed to the secretary of state for final sign-off; officials say delivery could help rural patients and those in long-term care, using licensed producers and the U.S. Postal Service as a primary channel. Research & Safety (Cannabinoids/Anxiety): A new mouse study links cannabinoid drug exposure to anxiety-related brain activity, suggesting potential targets to reduce anxiety symptoms when cannabis use goes sideways. Clinical/Patient Impact (Autism): A government study cited in coverage reports medical marijuana can help people with autism reduce anxiety and depression, adding to the growing body of patient-focused findings. Industry/Nonprofit Partnership (Cannatrol): Cannatrol’s Cool Cure Limited Edition program added Operation Green Healing as its exclusive veterans nonprofit partner, with proceeds supporting veterans’ wellness and alternative wellness education. Legal/Market (Tilray stock): Tilray shares are down sharply in 2026, with commentary pointing to how past downturns have played out for the company and why it remains a high-risk buy. Public Debate (Violence & cannabis): A large review finds cannabis users show higher odds of both committing and experiencing violence, while stressing it can’t prove cannabis causes harm. Legal Dispute (New Jersey): A New Jersey state senator is facing a lawsuit alleging a “de facto cartel” scheme tied to cannabis business benefits.